Biotron Limited

ASX (AUD): Biotron Limited (BIT)

Last Price

0.021

Today's Change

+0.003 (16.66%)

Day's Change

0.019 - 0.022

Trading Volume

3,117,631

Profile
BIT

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Michelle Miller BSc., GCertAppFin, MSc., Ph.D. Dr. Michelle Miller BSc., GCertAppFin, MSc., Ph.D.

Full Time Employees:  4 4

IPO Date:  2001-01-23 2001-01-23

CIK: 

ISIN:  AU000000BIT4 AU000000BIT4

CUSIP:  Q1527U107 Q1527U107

Beta:  -0.64 -0.64

Last Dividend:  0.00 0.00

Dcf Diff:  0.02 0.02

Dcf:  0.00 0.00

Description

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.

Address

66 Hunter Street,
Sydney, NSW 2000, AU

61 2 9300 3344

http://www.biotron.com.au

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment